Modernas stock price (MRNA) kept rising in the intraday levels, amid the dominance of the upward correctional trend in the short term, with positive signals from the RSI despite reaching overbought levels, while gaining support from trading above the 50-day SMA.

Therefore we expect more gains for the stock, targeting the resistance of $163.00, provided the support of $116.00 holds on.

Trend forecast: Likely Bullish